Table of contents
- Latest News on the Covidien Hernia Mesh Lawsuit
- November 2026
- August 2026
- June 2026
- February 2023
- February 2021
- October 2018
- What Is Covidien Hernia Mesh?
- Which Covidien Hernia Mesh Products Are Involved?
- Parietex Mesh
- Symbotex Composite Mesh
- ProGrip Mesh
- What’s the Problem With Covidien Hernia Mesh?
- What Complications Are Associated With Hernia Mesh?
- Chronic Pain
- Adhesions and Bowel Obstruction
- Mesh Migration and Contraction
- Infection
- Hernia Recurrence
- What Does the FDA Say About Hernia Mesh?
- Were Covidien Hernia Mesh Products Recalled?
- What Is the Covidien Hernia Mesh MDL?
- What Happened in the Covidien Bellwether Trial?
- Could Covidien or Medtronic Be Liable for Mesh Injuries?
- Who May Be Affected by Covidien Hernia Mesh?
- Do I Qualify for a Covidien Hernia Mesh Lawsuit?
- What Evidence Is Important in a Covidien Hernia Mesh Lawsuit?
- What Compensation May Be Available?
- Speak With a Covidien Hernia Mesh Lawyer
- How Does a Covidien Hernia Mesh Lawsuit Work?
- Frequently Asked Questions
- What is the Covidien Hernia Mesh Lawsuit?
- Which Covidien hernia mesh products are involved?
- Was Covidien hernia mesh recalled?
- What complications are associated with hernia mesh?
- What happened in the $88 million Covidien trial?
- Can I file a Covidien Hernia Mesh Lawsuit?
- Is there a Covidien hernia mesh settlement?
- References
Covidien, a subsidiary of Medtronic, manufactures surgical mesh products including Parietex, Symbotex, and ProGrip. The U.S. Food and Drug Administration (FDA) has also documented limited recalls involving specific Parietex products, although not every Covidien hernia mesh implant has been recalled.
Patients experiencing serious complications following Covidien mesh implantation may qualify for an individualized product-liability evaluation. However, a postoperative complication does not automatically establish that an implant was defective or that its manufacturer is legally responsible.
Quick Facts
- Products: Covidien Parietex, Symbotex, ProGrip, and related hernia mesh implants.
- Litigation: MDL 3029 in Massachusetts, with 2,486 pending federal cases reported as of November 2, 2026.
- Potential complications: Chronic pain, adhesions, bowel obstruction, infection, mesh migration, and hernia recurrence.
- Latest development: A federal judge indicated November 10, 2026, that an $88 million Symbotex jury verdict would be reduced.
Latest News on the Covidien Hernia Mesh Lawsuit
November 2026
On November 10, 2026, U.S. District Judge Patti B. Saris indicated that she would reduce an $88 million jury award against Medtronic’s Covidien unit. The verdict involved allegations that Symbotex hernia mesh caused bowel obstruction and that Covidien failed to adequately warn about potential risks [1].
The original award included $77 million for plaintiff Larry Patterson and $11 million for his wife. Judge Saris questioned the size of the award, but a final reduced amount had not been established in the November 11 sources reviewed.
The verdict remains subject to post-trial proceedings. Any reduction or subsequent judgment would apply to that case rather than automatically determine compensation for other plaintiffs.
The Judicial Panel on Multidistrict Litigation’s November 2, 2026 report identified 2,486 pending actions and 2,496 historical actions associated with Covidien MDL 3029. The proceeding remains before Judge Saris in the U.S. District Court for the District of Massachusetts [2].
These figures concern federal multidistrict litigation and do not represent every Covidien-related claim in state courts. The pending and historical totals measure different categories and should not be combined.
August 2026
On August 4, 2026, a federal jury returned an $88 million compensatory damages verdict in the first Covidien hernia mesh bellwether trial. Patterson alleged that Symbotex mesh implanted during a 2017 hernia repair adhered to his bowel and contributed to an obstruction requiring surgery in 2020.
The jury found Covidien liable for failing to provide adequate warnings. Covidien disputed the allegations, maintaining that other medical and surgical factors contributed to the patient’s complications.
June 2026
On June 5, 2026, the federal court issued a memorandum addressing expert testimony concerning Symbotex. The decision examined proposed opinions about polyester mesh, inflammatory responses, causation, and alternative designs [3].
The court allowed portions of the proposed expert testimony while excluding others. This evidentiary ruling did not independently establish that every Symbotex implant was defective.
February 2023
On February 27, 2023, the FDA posted a Class II recall involving Parietex Composite Mesh, model PCO2H3, lot PVE0194M. The recall concerned a manufacturing problem in which the absorbable collagen film was applied to the opposite side of the mesh [4].
The FDA identified 53 units in commerce and warned of potential complications including adhesions, erosion or migration, pain, fistula, and hernia recurrence. The FDA record reviewed on November 11, 2026, continued to display the status “Open, Classified.”
February 2021
The FDA posted another Class II recall involving Parietex Hydrophilic Anatomical Mesh, item TECT1510AL, lot SUH0709M. The packaging identified a left-sided implant, but the package contained a right-sided device [5].
The recall involved 129 units worldwide and identified potential implant failure or hernia recurrence. FDA records show that the recall was terminated on February 14, 2023.
October 2018
Covidien initiated a voluntary removal of Parietex Composite Parastomal Mesh following reports of mesh failure and recurrent parastomal hernias. The company identified 10 worldwide reports of mesh failure associated with the affected product during the preceding five years [6].
The recall involved 7,333 units and was terminated on May 7, 2020. This action concerned specific parastomal mesh products rather than all Covidien hernia mesh implants.
| Event | Month/Year | Type | Status | Source | Notes |
|---|---|---|---|---|---|
| Verdict reduction hearing | November 2026 | Federal litigation | Post-trial proceedings | [1] | Final reduced amount not established |
| MDL 3029 case statistics | November 2026 | Federal litigation | Active | [2] | 2,486 pending federal actions |
| Patterson jury verdict | August 2026 | Bellwether trial | Under post-trial review | [1] | Original $88 million award |
| Symbotex expert testimony ruling | June 2026 | Federal court decision | Issued | [3] | Expert opinions examined |
| Parietex Composite recall | February 2023 | FDA Class II recall | Open in FDA database | [4] | Collagen film positioned incorrectly |
| Parietex Anatomical recall | February 2021 | FDA Class II recall | Terminated | [5] | Incorrect device inside packaging |
| Parastomal mesh removal | October 2018 | FDA Class II recall | Terminated | [6] | Mesh failure and hernia recurrence |
What Is Covidien Hernia Mesh?
Covidien hernia mesh refers to surgical implants manufactured or marketed by Covidien, now part of Medtronic. The devices reinforce weakened abdominal or groin tissue during hernia repair.
Mesh may reduce hernia recurrence compared with certain repairs performed using sutures alone. However, individual products differ in composition, coatings, and fixation methods.
Which Covidien Hernia Mesh Products Are Involved?
Parietex Mesh
Parietex products use polyester mesh for tissue reinforcement. Some configurations incorporate absorbable collagen-based barriers intended to reduce unwanted tissue attachment.
Products include Parietex Composite Mesh, Parietex Hydrophilic Anatomical Mesh, and Parietex Composite Parastomal Mesh. Their separate configurations and recall histories make accurate implant identification important.
Symbotex Composite Mesh
Symbotex combines permanent polyester mesh with an absorbable collagen-based barrier. The barrier is intended to reduce adhesions when the implant is placed near abdominal organs.
The Patterson case involved allegations that Symbotex caused bowel complications and that its warnings were inadequate. Covidien contested those allegations.
ProGrip Mesh
ProGrip is a self-gripping surgical mesh designed to assist fixation during hernia repair. Its construction differs from coated Symbotex and certain Parietex products.
ProGrip products have also been identified in Covidien litigation. Allegations involving one mesh design should not automatically be attributed to another.
What’s the Problem With Covidien Hernia Mesh?
Covidien mesh litigation centers on allegations that certain implants were defectively designed or inadequately labeled. Plaintiffs have raised concerns about adhesions, bowel injuries, inflammation, chronic pain, and recurrent hernias.
Some claims involving coated polyester mesh question whether the absorbable barrier provides sufficient protection against tissue attachment over time. These allegations must be evaluated against the particular device, surgical circumstances, and medical evidence.
The FDA recalls involve separate manufacturing, packaging, and product-performance issues. Neither a limited recall nor the existence of litigation establishes that every Covidien mesh implant is defective.
What Complications Are Associated With Hernia Mesh?
The FDA identifies several complications associated with hernia repair and surgical mesh, including pain, infection, adhesions, bowel obstruction, bleeding, fistula, seroma, and hernia recurrence [7].
Chronic Pain
Persistent abdominal or groin pain may result from scar tissue, nerve irritation, inflammation, recurrence, or complications involving the implanted mesh. Some patients require specialist evaluation or further treatment.
Adhesions and Bowel Obstruction
Adhesions occur when internal tissues become abnormally attached. Severe adhesions may interfere with intestinal movement and sometimes require additional surgery.
Mesh Migration and Contraction
Mesh migration occurs when an implant moves from its intended position. Contraction or shrinkage may place tension on surrounding tissue and contribute to discomfort.
Infection
Infections involving implanted mesh may cause persistent inflammation, drainage, fever, or wound complications. Serious infections sometimes require hospitalization or implant removal.
Hernia Recurrence
A hernia may return after repair with or without mesh. Recurrence sometimes requires another operation, particularly when accompanied by pain or obstruction.
These complications are not unique to Covidien products. Determining whether an implant contributed to an individual patient’s condition requires medical evaluation.
What Does the FDA Say About Hernia Mesh?
The FDA recognizes benefits from mesh reinforcement but advises patients to discuss potential complications and treatment alternatives with their healthcare providers. The agency has not banned surgical mesh used for hernia repair generally.
Its 2019 action restricting transvaginal mesh for pelvic-organ-prolapse repair concerned a different medical application [8].
FDA clearance does not guarantee that every implant will be complication-free. Patients should evaluate concerns using their surgical records and the regulatory history of their specific device.
Were Covidien Hernia Mesh Products Recalled?
Yes. FDA records document limited Covidien recalls involving incorrectly positioned collagen barriers, mismatched packaging, and reported parastomal mesh failures.
The 2023 Parietex Composite recall involved 53 units from lot PVE0194M. The FDA database continues to list this action as open, classified, although the record does not establish that every affected device was implanted.
The 2021 Parietex Anatomical recall involved 129 units worldwide, while the 2018 Parastomal Mesh action involved 7,333 units. Both recalls were subsequently terminated.
Patients should obtain their operative reports and implant identification records to determine whether a particular recall applies. A Covidien product name alone does not establish recall eligibility.
What Is the Covidien Hernia Mesh MDL?
The federal litigation is consolidated as In re Covidien Hernia Mesh Products Liability Litigation (No. II), MDL 3029, in the District of Massachusetts.
Multidistrict litigation coordinates lawsuits sharing common factual questions for pretrial proceedings. It is not a class action, and plaintiffs retain individual claims involving their injuries and damages.
Judge Patti B. Saris oversees the proceeding, which remains active. The November 2026 case statistics document thousands of pending federal actions.
What Happened in the Covidien Bellwether Trial?
The first bellwether involved Larry Patterson, who received Symbotex mesh during a 2017 hernia repair. He alleged that the device adhered to his bowel and contributed to an obstruction requiring another operation.
The August 2026 jury awarded $88 million after finding Covidien failed to provide adequate warnings. The judge subsequently indicated that the award would be reduced, leaving its final amount unresolved as of the November 11 review.
Bellwether trials help parties assess disputed evidence and potential case outcomes. Their results do not automatically determine compensation for other plaintiffs.
Could Covidien or Medtronic Be Liable for Mesh Injuries?
Patients may pursue product-liability claims when evidence supports allegations that defective or inadequately labeled mesh caused an injury. Potential theories include inadequate warnings, design defects, manufacturing defects, negligence, or breach of warranty.
Legal responsibility depends on the implanted device, alleged defect, medical causation, damages, and applicable law. The Patterson verdict concerns one case and does not establish liability for every Covidien implant.
Who May Be Affected by Covidien Hernia Mesh?
Patients who received Covidien mesh during hernia repair and later developed serious complications may have grounds for medical and legal evaluation.
Relevant conditions include bowel obstruction, adhesions, infection, recurrent hernia, chronic pain, and complications requiring revision surgery or mesh removal.
Patients without symptoms should not assume removal is necessary. Treatment decisions should be made with qualified healthcare professionals.
Do I Qualify for a Covidien Hernia Mesh Lawsuit?
The following questions may help determine whether a potential claim warrants further review:
- Were you implanted with Covidien Parietex, Symbotex, ProGrip, or another Covidien hernia mesh product?
- Did you develop chronic pain, adhesions, bowel obstruction, infection, mesh migration, or hernia recurrence?
- Did your complications require hospitalization, revision surgery, mesh removal, or substantial additional treatment?
- Do you have surgical records, implant identification information, diagnostic imaging, or other medical documentation?
Answering yes does not establish eligibility or guarantee compensation. An attorney can evaluate the implant, alleged defect, causation, damages, and applicable filing deadlines.
What Evidence Is Important in a Covidien Hernia Mesh Lawsuit?
Accurate product identification matters because Covidien manufactures several mesh designs and its recalls involve specific products and lots.
Relevant evidence may include:
- Original operative and hospital records
- Mesh manufacturer, model, and lot number
- Implant stickers or unique device identifiers
- Medical imaging and diagnostic findings
- Documentation of obstruction, infection, or recurrence
- Revision surgery or mesh removal records
- Pathology findings involving removed material
- Medical bills and lost-income documentation
Patients can request implant details from their surgeon or surgical facility. Medical device problems may also be reported through the FDA’s MedWatch program.
What Compensation May Be Available?
Potential damages in qualifying claims may include medical expenses, revision surgery costs, future treatment, lost income, reduced earning capacity, pain and suffering, and other legally recognized losses.
Serious complications may require repeated procedures or long-term treatment. Compensation amounts vary by case. Past results do not guarantee future outcomes.
Speak With a Covidien Hernia Mesh Lawyer
If you developed serious complications following Covidien hernia mesh implantation, a product-liability attorney can review your surgical records, device identification, and medical findings. A free case review can help determine whether the evidence and applicable law support a potential injury claim.
How Does a Covidien Hernia Mesh Lawsuit Work?
- Free case review. An attorney evaluates the implant, medical history, complications, and supporting documentation.
- Investigation. Evidence may include operative reports, FDA records, medical testing, and expert evaluations.
- Filing. If supported by the evidence and applicable law, a legal claim may be filed against potentially responsible parties.
- Discovery/negotiation. The parties exchange evidence, assess causation and damages, and may discuss settlement.
- Resolution. A case may conclude through settlement, dismissal, court ruling, or trial.
Frequently Asked Questions
What is the Covidien Hernia Mesh Lawsuit?
The Covidien Hernia Mesh Lawsuit involves product-liability claims alleging injuries associated with certain Covidien surgical mesh implants. Thousands of federal actions are consolidated in MDL 3029 in Massachusetts.
Which Covidien hernia mesh products are involved?
Products identified in litigation include Symbotex, Parietex, and ProGrip mesh. Specific allegations differ by device, making accurate implant identification important.
Was Covidien hernia mesh recalled?
Yes. The FDA documents limited recalls involving specific Parietex products, including a 2023 collagen-barrier placement issue and a 2021 packaging discrepancy. These recalls did not include every Covidien mesh implant.
What complications are associated with hernia mesh?
Potential complications include chronic pain, infection, adhesions, bowel obstruction, mesh migration, contraction, and recurrence. These risks are associated with hernia repair generally and do not establish that every Covidien product is defective.
What happened in the $88 million Covidien trial?
An August 2026 federal jury awarded $88 million to a Symbotex patient and his wife following a failure-to-warn verdict. In November, the judge indicated that the award would be reduced, but the final amount remained unresolved in the sources reviewed.
Can I file a Covidien Hernia Mesh Lawsuit?
Patients experiencing serious complications after receiving Covidien mesh may have potential claims if the evidence and applicable law support liability. Eligibility depends on device identification, causation, damages, and filing deadlines.
Is there a Covidien hernia mesh settlement?
The November 2026 records establish active federal litigation and an individual bellwether verdict, not a finalized nationwide settlement program. Any later settlement or judgment must be confirmed through updated court records.
References
- https://www.reuters.com/legal/litigation/us-judge-slash-88-million-hernia-mesh-jury-award-against-medtronic-2026-11-10/
- https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_Actions_Pending-November-2-2026.pdf
- https://www.govinfo.gov/content/pkg/USCOURTS-mad-1_22-md-03029/pdf/USCOURTS-mad-1_22-md-03029-5.pdf
- https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=198189
- https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=185490
- https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=168668
- https://www.fda.gov/medical-devices/implants-and-prosthetics/surgical-mesh-used-hernia-repair
- https://www.fda.gov/medical-devices/implants-and-prosthetics/urogynecologic-surgical-mesh-implants



















